1 min read
CytomX to Receive $5 Million From Regeneron for Cancer Drug Milestone
The payment is tied to a preclinical milestone in the companies’ cancer drug development partnership.

CytomX Therapeutics, Inc. announced that it will receive $5 million from Regeneron after reaching a preclinical milestone in their cancer drug development partnership.